Organization
Jiangsu Simcere Biologics
1 clinical trial
Clinical trial
An Open-label, Phase I Trial of SIM1811-03 to Assess the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics in Subjects With Advanced TumorsStatus: Recruiting, Estimated PCD: 2025-06-30